FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Börse Stuttgart 11:47:02 24/05/2024 pm IST | ||
| 10.6 EUR | +1.24% |
|
| Current month | +3.01% | ||
| 1 month | +18.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 10.6 | +1.24% |
| 23/24/23 | 10.47 | +1.16% |
| 22/24/22 | 10.35 | +4.86% |
| 21/24/21 | 9.87 | +0.20% |
| 20/24/20 | 9.85 | +1.23% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 11:47 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG1KUV |
| ISIN | DE000MG1KUV8 |
| Date issued | 03/04/2024 |
| Strike | 72.78 € |
| Maturity | Unlimited |
| Parity | 2.29 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.07 € |
|---|---|
| Lowest since issue | 8.93 € |
| Spread | 0.18 € |
| Spread % | 1.67% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.34
EUR
Average target price
52.24
EUR
Spread / Average Target
+8.07%
- Stock Market
- Certificates
- Certificat
